Holly Rockweiler is unfazed by people who titter nervously when she describes the product Madorra manufactures: a medical device that helps relieve vaginal dryness for breast cancer survivors and post-menopausal women.
“It’s a huge problem,” she says.
Rockweiler, 31, incubated the company as part of a Stanford Biodesign fellowship she received in 2014. Vaginal dryness is typically treated hormonally, but Madorra uses ultrasound waves to relieve symptoms; a typical application takes only five minutes daily, Rockweiler says. FDA approval is expected to move forward in about two years.
In the meantime, Rockweiler and her partner, Ryan Krone, relocated Madorra from San Francisco to Portland, where the startup has already landed nearly $500,000 from PitchFest and Angel Oregon.
The potential market for Madorra is enormous: 32 million women in the U.S. alone, Rockweiler says.